Nikkei 225 (NIKKEI.NDX)

Cours de clôture: 35 706.00 (+666.59), 25. avr 2025
Hold

Automatic technical analysis. Moyen terme, 25. avr 2025

Nikkei 225 fluctue dans un canal presque horizontal et un développement dans la même direction est indiqué. L'indice rencontre du support à environ 31300 points et de la résistance à environ 37100 points. Les hauts et les bas des volumes correspondent mal aux hauts et aux bas des prix. Ceci affaiblit le l'indice et augmente les chances d'une cassure vers le bas. L'indice est généralement considéré comme neutre technique pour moyen long terme.

Recommendation one to six months: Hold

Période  
Vol.bal. Volatilité Liquidité +/- %
1 jour-1.06%134.70+1.90%
5 jours72.473.50%120.20+2.81%
22 jours-31.249.02%150.99-6.11%
66 jours-15.3018.04%127.27-10.92%

More analyses of Nikkei 225

chart Nikkei 225 (NIKKEI) Chandeliers 22 Days
Candlesticks
chart Nikkei 225 (NIKKEI) Court terme
Court terme: Conclusion légèrement négative
chart Nikkei 225 (NIKKEI) Moyen terme
Moyen terme: Hold
chart Nikkei 225 (NIKKEI) Long terme
Long terme : Conclusion légèrement positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.